D
Ascendis Pharma A/S ASND
$164.65 -$4.19-2.48%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 391.82M 354.67M 343.38M 356.22M 288.14M
Total Other Revenue -- -- -- -- --
Total Revenue 391.82M 354.67M 343.38M 356.22M 288.14M
Cost of Revenue 47.82M 53.82M 49.55M 51.28M 48.02M
Gross Profit 344.00M 300.86M 293.83M 304.94M 240.12M
SG&A Expenses 314.76M 298.13M 290.60M 287.11M 285.97M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 694.54M 697.23M 725.86M 748.58M 781.23M
Operating Income -302.73M -342.55M -382.49M -392.36M -493.10M
Income Before Tax -404.79M -452.24M -520.17M -535.34M -513.36M
Income Tax Expenses 5.25M 10.32M 9.90M 9.19M 7.86M
Earnings from Continuing Operations -410.04 -462.57 -530.08 -544.53 -521.22
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -410.04M -462.57M -530.08M -544.53M -521.22M
EBIT -302.73M -342.55M -382.49M -392.36M -493.10M
EBITDA -287.02M -326.40M -365.98M -375.52M -476.24M
EPS Basic -7.14 -8.10 -9.35 -9.64 -9.26
Normalized Basic EPS -4.40 -4.95 -5.73 -5.93 -5.70
EPS Diluted -7.14 -8.10 -9.35 -9.64 -9.26
Normalized Diluted EPS -4.40 -4.95 -5.73 -5.93 -5.70
Average Basic Shares Outstanding 231.55M 228.32M 227.06M 225.93M 225.14M
Average Diluted Shares Outstanding 231.55M 228.32M 227.06M 225.93M 225.14M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings